Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.

AIDS research and therapy - 12 Sept 2017

Ahmed Yousuf, Tian Meijuan, Gao Yong

Abstract excerpt

The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to B-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to env Gene Products, Human Immunodeficiency Virus

Share to HIV Antibodies

Share to HIV Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 28893278
DOI: 10.1186/s12981-017-0178-3
PMCID: PMC5594608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.PMID 28893278Read ↗

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.Semantic proximity Read ↗

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Semantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

Broadly Neutralizing Antibodies for HIV EradicationSemantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesSemantic proximity Read ↗

Broadly neutralizing antibodies against HIV-1: Templates for a vaccineSemantic proximity Read ↗

A critical question for HIV vaccine development: which antibodies to induce?Semantic proximity Read ↗

The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and PreventionSemantic proximity Read ↗

Germline-Targeting Strategies to Induce bNAbs against HIV-1Semantic proximity Read ↗

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.Semantic proximity Read ↗

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.